Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Iqvia Holdings Inc (NY: IQV )

239.69 +15.12 (+6.73%)
Streaming Delayed Price Updated: 2:13 PM EDT, Jul 22, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Iqvia Holdings Inc

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
US Stocks Rebound As Tech Surges, CrowdStrike Continues Selloff, Oil Hits 1-Month Lows: What's Driving Markets Monday?
Wall Street started the new week on a positive note, with all major indices in the green. A rebound in tech stocks following last week’s dips bolstered overall investor sentiment. 
Via Benzinga
IQVIA Posts Upbeat Earnings, Joins Terex, Reddit And Other Big Stocks Moving Higher On Monday
Via Benzinga
IQVIA 'Is A Solid Investment' With Strong Competitive Positioning, Analyst Says After Better Than Expected Q2 Earnings
IQVIA Holdings Inc (NASDAQ:IQV) reported a second adjusted EPS of $2.64, up from $2.43, beating the consensus of $2.57. 
Via Benzinga
How Is The Market Feeling About IQVIA Hldgs?
Via Benzinga
5 Analysts Assess IQVIA Hldgs: What You Need To Know
Via Benzinga
Analyst Scoreboard: 4 Ratings For IQVIA Hldgs
Via Benzinga
Iqvia Bolts Higher After A Surprise Segment Beat Saved Its Second Quarter
The company's technology and analytics solutions business has struggled, until now. 
Via Investor's Business Daily
IQVIA Reports Second-Quarter 2024 Results
From IQVIA Holdings Inc.
Via Business Wire
IQVIA Named a Leader in Medical Affairs and Regulatory Operations by Everest Group
From IQVIA
Via Business Wire
IQVIA to Announce Second-Quarter 2024 Results on July 22, 2024
From IQVIA Holdings Inc.
Via Business Wire
(IQV) - Analyzing IQVIA Hldgs's Short Interest
Via Benzinga
Forecasting The Future: 8 Analyst Projections For IQVIA Hldgs
Via Benzinga
Peering Into IQVIA Hldgs's Recent Short Interest
Via Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
IQVIA’s SmartSolve® eQMS Wins 2024 MedTech Breakthrough Award “Best Use of Artificial Intelligence in Healthcare”
From IQVIA
Via Business Wire
IQVIA Launches “One Home” Clinical Trial Technology Platform – Solves Challenges and Reduces Overload at Sites
From IQVIA
Via Business Wire
IQVIA Institute: Innovative Therapies and Strong Pipeline to Combat Rise in Cancer Diagnoses
From IQVIA
Via Business Wire
Peering Into IQVIA Hldgs's Recent Short Interest
Via Benzinga
AbbVie, Amazon, Goldman Sachs And 2 Major Health Care Stocks On CNBC's 'Final Trades'
AbbVie Inc. has good dividend yield and attractive valuations, according to Jim Lebenthal of Cerity Partners. 
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
U.S. Medicines Spending Grew in 2023 as Greater Access Offset COVID-19-related Decline, Says IQVIA Institute
From IQVIA
Via Business Wire
IQVIA CFO Ron Bruehlman to Speak at the Bank of America Health Care Conference on May 14, 2024
From IQVIA Holdings Inc.
Via Business Wire
IQV Stock Earnings: IQVIA Hldgs Beats EPS, Beats Revenue for Q1 2024
IQV stock results show that IQVIA Hldgs beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. 
Via InvestorPlace
IQVIA Reports First-Quarter 2024 Results
From IQVIA Holdings Inc.
Via Business Wire
Analysts Are Pounding the Table on These 3 Stocks: April 2024
From pharmaceutical testing to expansive integration expanding infrastructure, here are three stocks with analyst recommendations to buy. 
Via InvestorPlace
IQVIA Celebrates Wendy Stewart and Susan Barnes, Winners of Healthcare Businesswoman's Association Luminary and Rising Star Awards
From IQVIA
Via Business Wire
IQVIA to Announce First-Quarter 2024 Results on May 2, 2024
From IQVIA Holdings Inc.
Via Business Wire
Salesforce & IQVIA Expand Partnership: Life Sciences Cloud Gets A Superpower Boost
Salesforce shares rise after partnership with IQVIA to develop Life Sciences Cloud for customer engagement. 
Via Benzinga
IQVIA and Salesforce Expand Global Partnership to Accelerate the Development of Life Sciences Cloud
From IQVIA
Via Business Wire
Madrigal Pharmaceuticals Wins Approval for the First Drug Targeting the Multibillion-Dollar NASH Market. Is the Stock a Screaming Buy?
Madrigal's Rezdiffra will have the NASH market all to itself -- at least for a while. 
Via The Motley Fool
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.